跳至主要内容
临床试验/NCT04896034
NCT04896034已完成不适用

Evaluation of the Efficacy of the Photobiomodulation on the Pelvi-perineal Pain in Patients in Immediate Post-partum Situation

Elsan2 个研究点 分布在 1 个国家目标入组 480 人开始时间: 2021年5月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
480
试验地点
2
主要终点
Evaluation of the effectiveness of photobiomodulation (PBM) on pain in immediate postpartum patients

研究概览

简要总结

Photobiomodulation (PBM), evaluated in this study, will be delivered by a CE marked class IIa medical device (MILTA technology), composed of a panel that gathers 18 emitters. This is an innovative, alternative, soft technology, based on a cross action of LED light emission, a low intensity nanopulsed laser and a magnetic tunnel. The sessions last 10 minutes each, in total in the study two sessions will be delivered.

详细描述

In a woman's life, maternity is an important stage that is not without consequences, not only in daily life but also in future life. Perineal pain syndrome is a problem frequently encountered in the postpartum period and the review of the literature shows that 95 to 100% of women who have given birth by the vaginal way and who present perineal lesions, suffer from perineal pain at 24 hours of the delivery and approximately 60% of them remain painful at 7 days of the delivery. This incidence can decrease to 42% and 11% respectively in the absence of perineal lesions.

Pain in the postpartum period can not only limit a woman's mobility and affect her quality of life, but can also interfere with the care of her child and thus with the establishment of a good mother-child relationship, and thus prevent her from fulfilling her new role as a mother. Finally, acute pain that is not treated can become chronic and affect long-term physical and psychological health.

Pain management in the immediate postpartum period currently involves the use of level 1 analgesics (paracetamol, NSAIDs), the effectiveness of which is uncertain, and level 2 analgesics (weak morphine derivatives, Acupan, Tramadol), which are more effective for pain, but are sometimes badly tolerated or contraindicated in the case of breastfeeding. Recently, several publications tend to show that alternative solutions would allow a more satisfactory approach to the management of painful patients.

In this study, the investigators propose to evaluate the benefit of an innovative analgesic treatment in the immediate postpartum period using photobiomodulation (PBM) by evaluating pain using a Visual Analog Scale. PBM, discovered in the 1950s, uses the properties of light. The PBM corresponds to all the non-thermal and non-cytotoxic biological effects caused by the exposure of tissues to light sources in the visible and near-infrared range. More precisely, certain wavelengths of the light spectrum (red-infrared) lead to a cascade of biological effects within the cell: reduction of pain, regulation of inflammation and acceleration of the healing process.

The objective of this study is to analyze the possibility of replacing chemical medication by a non-invasive, painless technology in patients who have just given birth. This technology is already used for anti-inflammatory and analgesic actions in indications such as stomatology, rheumatology, post-operation and traumatology. This is part of the field of NMIs (non-medicinal interventions).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

The experimental group (real device) and the control 1 group ( fake device) will be in double-blind, neither the investigator nor the patient will know the allocated group.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Woman aged 18 years or older
  • Primi or multiparous patient
  • Natural childbirth, regardless of the method of extraction (spontaneous, vacuum, forceps), and damage to the perineum (simple tear, episiotomy, obstetric anal sphincter injury)
  • Patients affiliated to a health insurance plan
  • Agreeing to participate in the study and having signed an informed consent

排除标准

  • Immediate complications related to the childbirth and requiring management in the continuing care unit (delivery haemorrhage, eclampsia, etc.)
  • Severe neonatal complications requiring reanimation.
  • Patient with a cardiac pacemaker
  • Presence of a disease and/or taking photo-sensitising treatment
  • Patient under legal protection

研究组 & 干预措施

" control 2 " standard pain management with medication

No Intervention

In first intention: PARACETAMOL: max 1 g x 4 / 24 h Second intention: IBUPROFEN: max 100 mg x 2 for 48 h Third intention: ACUPAN 20 mg in sugar 3 times per 24 h Last intention: ACTISKENAN 10 mg x 4 / 24 h

" control 1 " fake MILTA device

Placebo Comparator

Fake device (control 1) which emits 10% red light (and no infrared) so that the difference between the two machines cannot be seen with the naked eye. The magnets present in the real device are absent in the fake machine and replaced by inert materials of the same mass.

干预措施: " control 1 " fake MILTA device (Device)

MILTA Device

Experimental

The MILTA device used for the study is composed of a panel which gathers 18 emitters composed of red, green and blue LEDs, 3 nanopulsed infrared laser diodes (cold laser), 3 infrared diodes and a permanent magnet

干预措施: MILTA Device (Device)

结局指标

主要结局

Evaluation of the effectiveness of photobiomodulation (PBM) on pain in immediate postpartum patients

时间窗: 30 minutes after first PBM session for the experimental and control 1 groups

Evaluated the superiority of the experimental group (MILTA device) to control 1 (fake device) using a Visual Analog Scale (VAS) collected before and after pain management (1st session of PBM)

Evaluation of the effectiveness of photobiomodulation on pain in immediate postpartum patients

时间窗: 30 minutes after first PBM session for the experimental group or 30 minutes after analgesic treatment for the group control 2

Evaluated the non-inferiority with of the experimental group (MILTA device) to control 2 (standard of care) using a Visual Analog Scale (VAS) collected before and after pain management

次要结局

  • Evaluation of the improvement of postpartum comfort(30 minutes after second PBM session for the experimental and control 1 groups and 30 minutes after analgesic treatment for the group control 2 (Day 1))
  • Evaluation of the involvement of caregivers during the hospital stay(through the hospital stay, an average of 2 or 3 days)
  • Evaluation of the effectiveness of photobiomodulation on pain after the second PBM session(30 minutes after second PBM session for the experimental and control 1 groups)
  • Safety evaluation(through study completion, an average of 10 days)
  • Characterisation of pain(30 minutes after second PBM session for the experimental and control 1 groups and 30 minutes after analgesic treatment for the group control 2 (Day 1))
  • Evaluation of the total quantity of analgesics consumed during the hospital stay(through the hospital stay, an average of 2 or 3 days)

研究者

发起方
Elsan
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验